Akari Therapeutics, Plc
(NASDAQ) AKTX
Akari Therapeutics, Plc Financials at a Glance
Market Cap
$262.56M
Revenue (TTM)
$0.00
Net Income (TTM)
$17.30M
EPS (TTM)
$-19.27
P/E Ratio
-0.02
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Price
$5.51
Volume
154
Open
$5.28
Price
$5.51
Volume
154
Open
$5.28
Previous Close
$5.51
Daily Range
$5.28 - $5.51
52-Week Range
$3.25 - $63.20
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Price
$5.51
Volume
154
Open
$5.28
Previous Close
$5.51
Daily Range
$5.28 - $5.51
52-Week Range
$3.25 - $63.20
AKTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Akari Therapeutics, Plc
Industry
Biotechnology
Sector
Health CareEmployees
6
CEO
Abizer Gaslightwala, MBA
Website
www.akaritx.comHeadquarters
London, W1G 9RT, GB
AKTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-68%
Return on Capital
-49%
Return on Assets
-36%
Earnings Yield
-50.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$262.56M
Shares Outstanding
45.27M
Volume
154
Short Interest
0.00%
Avg. Volume
15.89K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$17.27M
EBITDA
$17.35M
Operating Cash Flow
$10.57M
Capital Expenditure
$0.00
Free Cash Flow
$10.57M
Cash & ST Invst.
$5.20M
Total Debt
$754.00K
Akari Therapeutics, Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$262.56M
N/A
Market Cap/Employee
$32.82M
N/A
Employees
8
N/A
Net Income
$5.30M
-40.5%
EBITDA
$4.49M
-23.1%
Quarterly Fundamentals
Net Cash
$4.45M
+773.1%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$754.00K
-76.9%
Return on Assets
-36.12%
N/A
Return on Invested Capital
-48.61%
N/A
Free Cash Flow
$3.04M
-43.1%
Operating Cash Flow
$3.04M
-43.1%